Company / EPS (Diluted)
Guardant Health, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.28
FY2025
5-year range
-$6.41 / -$0.84
FY2021-FY2025
Trend
+33.2%
vs FY2024
Sector context
#147 of 159
Health Care
What the data says
Among 159 Health Care companies, Guardant Health, Inc. is in the bottom 8% for eps (diluted). EPS (Diluted) returned to growth in FY2025 after 3 years of decline, reaching $-4.28.
Based on SEC 10-K filings.
-4.28 in FY2025.
Declined from $-4.00 to $-4.28 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 159This company -$4.28 Sector average $1.64
▼
-361.2% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 33.2% year-over-year.
- Ranks #147 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.28 | +33.2% |
| FY2024 | -$6.41 | -60.3% |
| FY2023 | -$4.00 | -53.8% |
| FY2022 | -$2.60 | -209.5% |
| FY2021 | -$0.84 | +70.0% |
| FY2020 | -$2.80 | +60.4% |
| FY2019 | -$7.07 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026